ALKEM LABORATORIES
Back to Balance Sheet
|
ALKEM LABORATORIES Last 5 Year Deferred Tax Assets / Liabilities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Deferred Tax Assets / Liabilities | ₹-1,804 Cr | ₹-1,738 Cr | ₹-1,515 Cr | ₹-1,303 Cr | ₹-1,309 Cr |
What is the latest Deferred Tax Assets / Liabilities ratio of ALKEM LABORATORIES ?
| Year | Deferred Tax Assets / Liabilities |
|---|---|
| Mar2026 | ₹-1,804 Cr |
| Mar2025 | ₹-1,738 Cr |
| Mar2024 | ₹-1,515 Cr |
| Mar2023 | ₹-1,303 Cr |
| Mar2022 | ₹-1,309 Cr |
How is Deferred Tax Assets / Liabilities of ALKEM LABORATORIES Trending?
| Years | Deferred Tax Assets / Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹-1,804 Cr | Negative | |
| Mar2025 | ₹-1,738 Cr | Negative | |
| Mar2024 | ₹-1,515 Cr | Negative | |
| Mar2023 | ₹-1,303 Cr | Negative | |
| Mar2022 | ₹-1,309 Cr | - | |
Compare Deferred Tax Assets / Liabilities of peers of ALKEM LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ALKEM LABORATORIES | ₹61,817.1 Cr | 0.6% | 3.7% | -10.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹452,299.0 Cr | 1% | 7.5% | 7.9% | Stock Analytics | |
| DIVIS LABORATORIES | ₹297,325.0 Cr | 0.8% | 22.8% | 71.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹178,727.0 Cr | 0.2% | 1.9% | 20.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹116,145.0 Cr | 0.8% | 12.2% | 12.3% | Stock Analytics | |
| CIPLA | ₹114,312.0 Cr | 1.5% | 6.4% | -7.8% | Stock Analytics | |
ALKEM LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ALKEM LABORATORIES | 0.6% |
3.7% |
-10.1% |
| SENSEX | 2.9% |
13.9% |
-0.8% |
You may also like the below Video Courses